From the Departments of Neurology (R.J.P.), Pediatrics (R.J.P.), and Neuroradiology (G.V.), Children's National Medical Center, The George Washington University Medical Center, Washington, DC; Division of Human Genetics (J.A.B.), Pediatrics (J.A.B., A.J.J.), and Neuropathology (L.B.R.), Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas (S.B.); Department of Pediatrics, New York University, New York, New York (J.F.); Department of Pediatrics, Children's Regional Medical Center, University of Washington, Seattle, Washington (J.R.G.);, Departments of Pediatrics (R.H.) and Radiation Oncology (L.K.), St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, Cleveland Clinic Foundation, Cleveland, Ohio (J.H.); and National Cancer Institute, Bethesda, Maryland (M.S.), U.S.A.
Submitted for publication April 26, 2001; accepted July 30, 2001.
Sponsored by the Office of Rare Diseases of the National Institutes of Health, the National Cancer Institute, and the Pediatric Brain Tumor Foundation of the United States.
Address correspondence and reprint requests to Roger J. Packer, M.D., Executive Director, Center for Neuroscience and Behavioral Medicine, Chairman, Department of Neurology, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010 U.S.A. E-mail: [email protected]
